|
Opportunities for Proteomics Technology Markets in EuropePublished by: Frost & Sullivan Published: Sep. 30, 2005 - 68 Pages Table of Contents1. Executive Summary 2. Glossary 3. Total Market 4. Protein Separation Technology 5. Protein Identification Technology 6. Frost & Sullivan Awards 7. Strategic Recommendations 8. DSD for Proteomics 9. Database of key Industry Participants(DKIP) AbstractLow Return on Investment that can Dissuade Potential Entrants in Proteomics Technology Markets Offset by Increasing Public Funding Proteomic research requires huge capital investments and currently, yields poor revenues. Companies, therefore, infer that the market lifecycle is at a stage where they need to wait before witnessing profits. In addition, pharmaceutical companies are doubtful about adopting this new technology in their drug development pipeline as they are wary of premium pricing. However, public funding institutions are giving importance to this growing biological discipline next to comparative genomics. The proteomics market is considered an emerging area with immense potential. In fact, Governments and federal ministries in the three major countries, namely the United Kingdom, France and Germany, are allocating thematic priorities to nurture the growth of this market. This is likely to result in greater industrialization of this field, which in turn, will boost the confidence of companies to invest in this fast-paced and dynamic arena. This Frost & Sullivan research service discusses the opportunities for proteomics technology in Europe and divides proteomics by application segments into protein separation and identification technology. This study analyses the competitive market scenario, highlights industry challenges and offers valuable strategic recommendations to counter these setbacks. In addition, it also offers analysis of revenues by segments. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||